LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $61,234 | $61,255 | $61,255 |
| - Cash | $22,978 | $14,979 | $21,404 |
| + Debt | $3,703 | $0 | $24,148 |
| Enterprise Value | $41,959 | $46,276 | $63,999 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$63,010 | -$1,445 | -$12,194 |
| % Margin | – | – | – |
| Net Income | -$63,102 | -$6,275 | -$14,348 |
| % Margin | – | – | – |
| EPS Diluted | -17.83 | -1.77 | -4.05 |
| % Growth | -907.3% | 56.3% | – |
| Operating Cash Flow | -$53,052 | -$12,094 | -$2,728 |
| Capital Expenditures | -$769 | -$25 | $0 |
| Free Cash Flow | -$53,821 | -$12,119 | -$2,728 |